Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Coursaget

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 21, 2013
Human Merkel cell polyomavirus: virological background and clinical implicationsPierre Coursaget, Mahtab Samimi, Jérome T J Nicol, et al.
The Journal of General Virology|August 22, 2000
Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16Fabien Dorange, Slimane El Mehdaoui, Chantal Pichon, et al.
Virology|May 3, 2003
Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitopeJean-Rémy Sadeyen, Sylvie Tourne, Marina Shkreli, et al.
Protein Science : a Publication of the Protein Society|June 18, 2009
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implicationsMaxime J J Fleury, Antoine Touzé, Marie-Christine Maurel, et al.
The Journal of General Virology|November 21, 2001
Gene transfer using human polyomavirus BK virus-like particles expressed in insect cellsAntoine Touzé, Latifa Bousarghin, Céline Ster, et al.
Salud Publica De Mexico|December 8, 2023
Prophylactic cancer vaccines: development and challenges for HBV and HPV vaccines in Latin AmericaLaura Ximena Ramírez-López, Martha Carnalla-Cortés, Tonatiuh Barrientos-Gutiérrez, et al.
Seminars in Oncology|April 7, 2015
Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectivesMahtab Samimi, Charlotte Gardair, Jérome T J Nicol, et al.
Presse Medicale (Paris, France : 1983)|October 31, 2008
[Merkel cell carcinoma: a virus-induced tumor?]Anabel Maruani, Emmanuelle Lebidre, Antoine Touzé, et al.
Plos One|May 13, 2014
Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomavirusesJérôme T J Nicol, Etienne Liais, Romain Potier, et al.
Emerging Infectious Diseases|July 31, 2012
Seroprevalence and cross-reactivity of human polyomavirus 9Jérôme T J Nicol, Antoine Touzé, Rémy Robinot, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 21, 2013
Human Merkel cell polyomavirus: virological background and clinical implicationsPierre Coursaget, Mahtab Samimi, Jérome T J Nicol, et al.
The Journal of General Virology|August 22, 2000
Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16Fabien Dorange, Slimane El Mehdaoui, Chantal Pichon, et al.
Virology|May 3, 2003
Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitopeJean-Rémy Sadeyen, Sylvie Tourne, Marina Shkreli, et al.
Protein Science : a Publication of the Protein Society|June 18, 2009
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implicationsMaxime J J Fleury, Antoine Touzé, Marie-Christine Maurel, et al.
The Journal of General Virology|November 21, 2001
Gene transfer using human polyomavirus BK virus-like particles expressed in insect cellsAntoine Touzé, Latifa Bousarghin, Céline Ster, et al.
Salud Publica De Mexico|December 8, 2023
Prophylactic cancer vaccines: development and challenges for HBV and HPV vaccines in Latin AmericaLaura Ximena Ramírez-López, Martha Carnalla-Cortés, Tonatiuh Barrientos-Gutiérrez, et al.
Seminars in Oncology|April 7, 2015
Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectivesMahtab Samimi, Charlotte Gardair, Jérome T J Nicol, et al.
Presse Medicale (Paris, France : 1983)|October 31, 2008
[Merkel cell carcinoma: a virus-induced tumor?]Anabel Maruani, Emmanuelle Lebidre, Antoine Touzé, et al.
Plos One|May 13, 2014
Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomavirusesJérôme T J Nicol, Etienne Liais, Romain Potier, et al.
Emerging Infectious Diseases|July 31, 2012
Seroprevalence and cross-reactivity of human polyomavirus 9Jérôme T J Nicol, Antoine Touzé, Rémy Robinot, et al.
Pageof 6